H C Whinna
Overview
Explore the profile of H C Whinna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
299
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raval J, Mazepa M, Russell S, Immel C, Whinna H, Park Y
Vox Sang
. 2015 Mar;
108(4):387-92.
PMID: 25753261
Background: Transfusion-associated circulatory overload (TACO) is the second leading cause of reported transfusion-related fatalities in the United States. While its occurrence has been previously investigated after red cell and plasma...
2.
Hawes E, Deal A, Funk-Adcock D, Gosselin R, Jeanneret C, Cook A, et al.
J Thromb Haemost
. 2013 May;
11(8):1493-502.
PMID: 23718677
Background: Knowledge of anticoagulation status during dabigatran therapy may be desirable in certain clinical situations. Objective: To determine the coagulation tests that are most useful for assessing dabigatran's anticoagulant effect....
3.
Cardenas J, Aleman M, Wang J, Whinna H, Wolberg A, Church F
J Thromb Haemost
. 2013 Mar;
11(5):990-2.
PMID: 23480546
No abstract available.
4.
Pastoft A, Lykkesfeldt J, Ezban M, Tranholm M, Whinna H, Lauritzen B
Haemophilia
. 2012 Apr;
18(5):782-8.
PMID: 22500820
Haemostatic effect of compounds for treating haemophilia can be evaluated in various bleeding models in haemophilic mice. However, the doses of factor VIII (FVIII) for normalizing bleeding used in some...
5.
Owens 3rd A, Lu Y, Whinna H, Gachet C, Fay W, Mackman N
J Thromb Haemost
. 2011 Sep;
9(9):1862-3.
PMID: 21884567
No abstract available.
6.
Cuker A, Ptashkin B, Konkle B, Pipe S, Whinna H, Zheng X, et al.
J Thromb Haemost
. 2008 Nov;
7(1):80-6.
PMID: 19017257
Background: In an effort to improve interlaboratory agreement in the monitoring of unfractionated heparin (UFH), the College of American Pathologists (CAP) recommends that the therapeutic range of the activated partial...
7.
Fortenberry Y, Whinna H, Cooper S, Myles T, Leung L, Church F
J Thromb Haemost
. 2007 Jul;
5(7):1486-92.
PMID: 17635698
Background: Protein C inhibitor (PCI) and antithrombin (AT) are serine protease inhibitors (serpins) that inhibit a wide array of blood coagulation serine proteases including thrombin. Objective: Fifty-five Ala-scanned recombinant thrombin...
8.
Hoffman M, Whinna H, Monroe D
J Thromb Haemost
. 2006 Sep;
4(9):2092-3.
PMID: 16961625
No abstract available.
9.
Whinna H, Lesesky E, Monroe D, High K, Larson P, Church F
J Thromb Haemost
. 2004 Jun;
2(7):1127-34.
PMID: 15219196
Background: Factor (F)Xa has 11 gamma-carboxylated glutamic acid (Gla) residues that are involved in calcium-dependent membrane binding. The serpin antithrombin (AT) is an important physiological regulator of FXa activity in...
10.
Holland C, Henry A, Whinna H, Church F
FEBS Lett
. 2000 Nov;
484(2):87-91.
PMID: 11068038
'Thrombin aptamers' are based on the 15-nucleotide consensus sequence of d(GGTTGGTGTGGTTGG) that binds specifically to thrombin's anion-binding exosite-I. The effect of aptamer-thrombin interactions during inhibition by the serine protease inhibitor...